In-vitro synthesis of functional varicella zoster and herpes simplex viral thymidine kinase
- PMID: 1698324
- DOI: 10.1007/BF00678403
In-vitro synthesis of functional varicella zoster and herpes simplex viral thymidine kinase
Abstract
The varicella zoster virus (VZV) and herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) genes were cloned into the transcription vector pGEM4. In-vitro translation (ivt) of RNA transcribed from these genes showed prominent expression of functional TK proteins with the expected molecular weights of 36 kD for VZV and 43, 39, and 38 kD for HSV-1. The TK proteins were recognized by rabbit anti-VZV and anti-HSV-1 antibodies, respectively. Analysis of the ivt products by thin-layer chromatography revealed the conversion of thymidine to its phosphorylated forms (TMP, TDP, and TTP) by both the VZV and HSV-1 TK genes. The estimated specific activities of the in-vitro translated VZV and HSV-1 TKs were comparable. VZV TK templates were linearized at internal restriction sites and RNAs transcribed from these templates directed the synthesis of polypeptides with sizes consistent with the colinearity of the VZV TK gene. Deletion of 107 amino acids at the carboxy terminus of the VZV TK gene abolished the in-vitro TK activity. In addition, immunoprecipitation of truncated proteins synthesized in vitro suggested the possible involvement of the region between amino acid residues 101 and 168 from the amino terminus of the VZV TK molecule in the formation of structures necessary for antigenicity.
Similar articles
-
Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK.J Virol. 1998 Dec;72(12):9535-43. doi: 10.1128/JVI.72.12.9535-9543.1998. J Virol. 1998. PMID: 9811686 Free PMC article.
-
Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.J Mol Model. 2014 Jul;20(7):2321. doi: 10.1007/s00894-014-2321-6. Epub 2014 Jun 25. J Mol Model. 2014. PMID: 24961898
-
Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus.Acta Virol. 1998 Dec;42(6):401-7. Acta Virol. 1998. PMID: 10358747
-
Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.Biochim Biophys Acta. 2002 Jul 18;1587(2-3):287-95. doi: 10.1016/s0925-4439(02)00091-1. Biochim Biophys Acta. 2002. PMID: 12084470 Review.
-
The varicella-zoster virus genome.Curr Top Microbiol Immunol. 2010;342:1-14. doi: 10.1007/82_2010_10. Curr Top Microbiol Immunol. 2010. PMID: 20225013 Free PMC article. Review.
Cited by
-
Distribution of latent herpes simplex virus type-1 and varicella zoster virus DNA in human trigeminal Ganglia.Virus Genes. 2005 Oct;31(2):223-7. doi: 10.1007/s11262-005-1799-5. Virus Genes. 2005. PMID: 16025248
-
Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment.J Virol. 1991 Dec;65(12):6407-13. doi: 10.1128/JVI.65.12.6407-6413.1991. J Virol. 1991. PMID: 1658351 Free PMC article.
-
Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.J Clin Microbiol. 2000 May;38(5):1839-44. doi: 10.1128/JCM.38.5.1839-1844.2000. J Clin Microbiol. 2000. PMID: 10790110 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources